Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hoth Therapeutics Inc
HOTH
Healthcare
Biotechnology
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s...
or other neuroinflammatory diseases (HT-ALZ). It also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for acne as well as inflammatory bowel diseases (HT-003). Its development products include HT-001, HT-KIT, HT-ALZ, and HT-TBI. Its BioLexa Platform is a proprietary, patented, drug compound platform for the treatment of eczema. The Company also has interests in certain other assets being developed by third parties including a treatment for patients with lupus.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:HOTH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 26, 2023 3:11pm
HOTH..... stopped out at $1.75
20 cent profit is better than nil.....I like to leave some for the next guy ; ) C u all tomorrow .... Cheers
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 26, 2023 2:36pm
HOTH..... Come on Mr. M....I figure you can give me
10 more cents Be a Sport !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 26, 2023 12:50pm
HOTH..... still processing
Right Mr. M ????
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 26, 2023 11:20am
HOTH....bot the dip....gonna sell this rip ; )
Cheers !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 26, 2023 9:15am
HOTH....early a.m halt on merger NR
On watch
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 08, 2023 9:03am
HOTH.....Rockin in the pre-market
Good news and volume & Price action Let goooooooooooooooooooooooo
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 08, 2023 8:56am
HOTH ....early a.m runner up on NR
Volume is picking up post NR...13 mins ago Cheers !
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 29, 2022 11:25am
HOTH...... If I told u.....u wouldn't believe me ; )
Best scalp this a.m It's not over.... $10.44 bid
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 08, 2021 9:39am
HOTH....1st entry...added on this dip
JMHO Lets see what happens
(70)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 07, 2021 2:38pm
HOTH ...... on watch
just back from halt
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth